Anthera Pharmaceuticals Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/18 Q1

ended 12/31/17 FY 2017

ended 09/30/17 Q3

ended 03/31/17 Q1 2017 – amended

ended 06/30/17 Q2

Prospectuses and Registrations Filter

Securities registration termination

Registration withdrawal request

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

McManigle Mark Drew

683 Capital Management, LLC

Anson Funds Management LP

Biotechnology Value Fund L P

Franklin Resources Inc.

News Filter

Announces SEC Deregistration

Announces Withdrawal of Its Nasdaq Hearing Request and Suspension of Trading of Its Securities on the NASDAQ Capital Markets

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness